Please assess the completion status of the following clinical trial:

Trial Title: Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or Female patients 18 years of age or older~2. Diagnosis of ESRD \[Glomerular Filtration Rate (GFR) ≤ 15 mL/min\]~3. CAPD using only Dianeal, at least 1 exchange of 2.5% or 4.25% dextrose/day, no prescribed dry time~4. Diabetes Mellitus (Type 1 and 2)~5. HbA1c \> 6.0% but ≤ 12.0%~6. Blood hemoglobin ≥ 8.0 g/dL, but ≤ 13.0 g/dL~7. Total Kt/V ≥ 1.7~Exclusion Criteria:~1. Blood Urea Nitrogen (BUN) \> 95 mg/dL~2. Exposure to Extraneal within 60 days of Screening~3. Mean Arterial Pressure (MAP) ≥ 125 mm Hg, or volume depleted (MAP \< 77mm Hg) at Screening~4. Peritonitis, exit-site or tunnel infection treated with antibiotics within last 30 days~5. Cardiovascular event within the last 30 days~6. Ongoing clinically significant congestive heart failure \[New York Heart Association (NYHA) class III or IV\]~7. Allergy to starch-based polymers, glycogen storage disease or isomaltose/maltose intolerance~8. Receiving rosiglitazone maleate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Non-glucose Sparing (Type: ACTIVE_COMPARATOR): Dianeal only
- Glucose Sparing (Type: EXPERIMENTAL): Dianeal, Extraneal, Nutrineal

Based on this trial design, predict the completion outcome and termination type (if applicable).